This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Medical University of Innsbruck, Vichem Chemie Kutato Korlatolt Felelossegu Tarsasag. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: János Pató: Innovator in Cyclin Dependent Kinase Inhibitors
Introduction
János Pató is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as cyclin dependent kinase inhibitors. His work is crucial in the ongoing fight against cancer and other proliferative diseases.
Latest Patents
János Pató holds a patent for "3-amino-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones as cyclin dependent kinase inhibitors." This invention relates to 3-amino-pyrazolo[3,4-d]pyrimidin-4-ones, which are particularly useful as cyclin dependent kinase (CDK) inhibitors. The patent details pharmaceutical compositions that include these compounds and their applications in the prophylaxis and treatment of cancer and other proliferative diseases. Additionally, the patent outlines processes for synthesizing these compounds and their intermediates.
Career Highlights
Throughout his career, János Pató has worked with esteemed institutions such as Medizinische Universität Innsbruck and Vichem Chemie Kutató Korlátolt Felelösségü Társaság. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.
Collaborations
János has collaborated with notable professionals in his field, including Winfried Wunderlech and Lukas A Huber. These collaborations have further enhanced his research and innovation capabilities.
Conclusion
János Pató's contributions to the field of pharmaceuticals, particularly through his patent on cyclin dependent kinase inhibitors, highlight his role as an innovator. His work continues to impact the treatment of cancer and other diseases, showcasing the importance of research and development in medicine.